These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33346046)
1. Synthesis, anticancer activity and potential application of diosgenin modified cancer chemotherapeutic agent cytarabine. Liao AM; Cai B; Huang JH; Hui M; Lee KK; Lee KY; Chun C Food Chem Toxicol; 2021 Feb; 148():111920. PubMed ID: 33346046 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate. Liao AM; Zhang Y; Hou Y; Huang JH; Hui M; Lee KK; Lee KY; Chun C Food Chem Toxicol; 2021 May; 151():112101. PubMed ID: 33684518 [TBL] [Abstract][Full Text] [Related]
3. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation. Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-tumour, immunomodulating activity of diosgenin and tigogenin conjugates. Michalak O; Krzeczyński P; Cieślak M; Cmoch P; Cybulski M; Królewska-Golińska K; Kaźmierczak-Barańska J; Trzaskowski B; Ostrowska K J Steroid Biochem Mol Biol; 2020 Apr; 198():105573. PubMed ID: 32017993 [TBL] [Abstract][Full Text] [Related]
5. [Novel derivatives of diosgenin: design, synthesis and anti-tumor activity]. Ding XY; He G; Jiang HP; Wan JF; Fan JZ Yao Xue Xue Bao; 2012 Apr; 47(4):479-85. PubMed ID: 22799030 [TBL] [Abstract][Full Text] [Related]
6. Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine. Schwendener RA; Schott H Int J Cancer; 1992 May; 51(3):466-9. PubMed ID: 1592536 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers. Sarpietro MG; Ottimo S; Giuffrida MC; Rocco F; Ceruti M; Castelli F Int J Pharm; 2011 Mar; 406(1-2):69-77. PubMed ID: 21219999 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of diosgenyl quaternary ammonium derivatives and their antitumor activity. Xia X; Chen Y; Wang L; Yang ZG; Ma XD; Zhao ZG; Yang HJ Steroids; 2021 Feb; 166():108774. PubMed ID: 33285175 [TBL] [Abstract][Full Text] [Related]
9. Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential. Denora N; Laquintana V; Trapani A; Lopedota A; Latrofa A; Gallo JM; Trapani G Mol Pharm; 2010 Dec; 7(6):2255-69. PubMed ID: 20958082 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of Diosgenin-Amino Acid Derivatives with Dual Functions of Neuroprotection and Angiogenesis. Cai D; Qi J; Yang Y; Zhang W; Zhou F; Jia X; Guo W; Huang X; Gao F; Chen H; Li T; Li G; Wang P; Zhang Y; Lei H Molecules; 2019 Nov; 24(22):. PubMed ID: 31703284 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of 1-beta-4-selenoarabinofuranosyl cytosine (4'-seleno-ara-C). Lee H; Tosh DK; Choi WJ; Kim YM; Lee SK; Jeong LS Nucleic Acids Symp Ser (Oxf); 2008; (52):639-40. PubMed ID: 18776542 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines. Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202 [TBL] [Abstract][Full Text] [Related]
13. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death. Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine. Liu B; Cui C; Duan W; Zhao M; Peng S; Wang L; Liu H; Cui G Eur J Med Chem; 2009 Sep; 44(9):3596-600. PubMed ID: 19321234 [TBL] [Abstract][Full Text] [Related]
15. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937. Horber DH; Schott H; Schwendener RA Cancer Chemother Pharmacol; 1995; 36(6):483-92. PubMed ID: 7554040 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and biological studies of diosgenyl analogues. Huang B; Du D; Zhang R; Wu X; Xing Z; He Y; Huang W Bioorg Med Chem Lett; 2012 Dec; 22(24):7330-4. PubMed ID: 23153797 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of N-acetylglucosamine-modified ara-C and its effect on ovarian cancer cells. Fujimoto H; Takayanagi T; Ajisaka K J Med Chem; 1994 Oct; 37(21):3668-70. PubMed ID: 7932594 [TBL] [Abstract][Full Text] [Related]